Treatment of ovarian hyperstimulation syndrome in a mouse model by cannabidiol, an angiogenesis pathway inhibitor

HIGHLIGHTS

• who: Kobra Tahermanesh and colleagues from the Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran have published the research: Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor, in the Journal: BioMed Research International 10 of 21/Dec/2022
• what: This study showed that the antiangiogenic activity of CBD is effective in counteracting OHSS development.
• how: In this study a SuperScript II Single-Strand cDNA Kit was used which contains Moloney murine leukemia virus reverse_transcriptase (M-MLV RT). In this study a Thermo Fisher Scientific . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.